Personalized Antidepressant Treatment Reduced Discontinuation In Major Depressive Disorder (17% vs. 27%)

People with major depressive disorder (MDD) who received a personalized antidepressant selected using a web-based clinical decision-support system were less likely to discontinue treatment within eight weeks. The discontinuation rate was 17% for those who received a personalized antidepressant prescription compared to 27% for those who received usual care. Discontinuation rates within eight weeks due to adverse effects were 9% among those who received personalized prescribing and 16% among the usual care group.

The decision support tool was developed during the Personalising Antidepressant Treatment for Unipolar Depression Combining Individual Choices, Risks and Big Data (PETRUSHKA) project. The researchers . . .